REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,286.00
Bid: 3,286.00
Ask: 3,152.00
Change: -44.00 (-1.32%)
Spread: -134.00 (-4.078%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,330.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Divestment of Omega Engineering completed

5 Jul 2022 07:00

RNS Number : 2816R
Spectris PLC
05 July 2022
 

Divestment of Omega Engineering completed

5 July 2022 - Further to the announcement of 19 April 2022, Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, today announces that the divestment of Omega Engineering ('Omega') to Arcline Investment Management for $525 million has completed, following receipt of the required regulatory approvals.

Following completion of the sale of Omega, Spectris will be made up of three businesses:Malvern Panalytical, HBK and Industrial Solutions, focused on high precision measurement solutions.

As a result, in the Group's upcoming first half results on 1 August, Omega will be reported as a discontinued operation under IFRS 5 and therefore excluded from the segmental analysis. The six months ended 30 June 2021 and twelve months ended 31 December 2021 will be restated to show continuing operations, including a reclassification of continuing head office expenses that were previously allocated to Omega being re-allocated to the three remaining businesses. These totalledapproximately £2.2 million in the first half of 2021 and £4.8 million for the full year.

A summary of the Group's re-stated sales and adjusted operating profit is presented below. This is still subject to final adjustments, with the full details to be provided in the upcoming first half results.

Malvern Panalytical

HBK

Omega

Industrial Solutions

Total

2021 half year by segment

H1 2021

H1 2021 restated

H1 2021

H1 2021 restated

H1 2021

H1 2021 restated

H1 2021

H1 2021 restated

H1 2021

H1 2021 restated

Sales (£m)

178.5

178.5

188.0

188.0

64.3

-

171.0

171.0

601.8

537.5

Adjusted operating profit (£m)

23.0

22.3

22.5

21.7

6.5

-

24.8

24.1

76.8

68.1

Adjusted operating margin (%)

12.9%

12.5%

12.0%

11.5%

10.1%

-

14.5%

14.1%

12.8%

12.7%

 

Malvern Panalytical

HBK

Omega

Industrial Solutions

Total

2021 full year by segment

FY 2021

FY 2021 restated

FY 2021

FY 2021 restated

FY 2021

FY 2021 restated

FY 2021

FY 2021 restated

FY 2021

FY 2021 restated

Sales (£m)

401.2

401.2

425.5

425.5

129.0

-

336.3

336.3

1,292.0

1,163.0

Adjusted operating profit (£m)

72.2

70.6

65.0

63.3

15.0

-

57.2

55.7

209.4

189.6

Adjusted operating margin (%)

18.0%

17.6%

15.3%

14.9%

11.6%

-

17.0%

16.6%

16.2%

16.3%

 

For and on behalf of Spectris plc

LEI Number: 213800Z4CO2CZO3M3T10

Contacts:

Spectris plc

Siobhán Andrews

Head of Corporate Affairs+44 20 4551 4549/+44 7920 230093

Tulchan Communications

Martin Robinson

Giles Kernick

+44 20 7353 4200

About Spectris

Spectris' global group of businesses are focused on delivering value beyond measure for all our stakeholders. We target global, attractive and sustainable markets, where growth and high returns are supported by long-term drivers. Precision is at the heart of what we do. We provide customers with expert insight through our advanced instruments and test equipment, augmented by the power of our software and services. This equips customers with the ability to reduce time to market, improve processes, quality and yield. In this way, Spectris know-how creates value for our wider society, as our customers design, develop, test and manufacture their products to make the world a cleaner, healthier and more productive place. Headquartered in London, United Kingdom, the Company employs approximately 7,350 people located in more than 30 countries. For more information, visit www.spectris.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSSMFWLEESEIW
Date   Source Headline
2nd May 20247:00 amRNSQ1 2024 trading update
1st May 20249:50 amRNSTotal Voting Rights
23rd Apr 20245:57 pmRNSDirector/PDMR Shareholding
9th Apr 20243:14 pmRNSDirector/PDMR Shareholding
8th Apr 20245:30 pmRNSHolding(s) in Company
3rd Apr 20246:26 pmRNSTransaction in Own Shares
3rd Apr 20245:20 pmRNSHolding(s) in Company
3rd Apr 20247:00 amRNSDivestment of Red Lion Controls completed
2nd Apr 20246:26 pmRNSTransaction in Own Shares
2nd Apr 202410:30 amRNSTotal Voting Rights
28th Mar 20246:29 pmRNSTransaction in Own Shares
28th Mar 202410:00 amRNSDirectorate Change
27th Mar 20245:56 pmRNSTransaction in Own Shares
27th Mar 20249:45 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20246:23 pmRNSTransaction in Own Shares
20th Mar 20246:44 pmRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:59 pmRNSTransaction in Own Shares
18th Mar 202411:37 amRNSDirector and Board Committee Membership Change
15th Mar 20246:10 pmRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20246:28 pmRNSTransaction in Own Shares
12th Mar 20246:06 pmRNSTransaction in Own Shares
11th Mar 20246:02 pmRNSTransaction in Own Shares
11th Mar 202412:33 pmRNSDirector/PDMR Shareholding
8th Mar 20246:00 pmRNSTransaction in Own Shares
8th Mar 20242:59 pmRNSDirector/PDMR Shareholding
7th Mar 20245:27 pmRNSTransaction in Own Shares
7th Mar 202411:32 amRNSDirector Declaration
6th Mar 20246:07 pmRNSTransaction in Own Shares
5th Mar 20246:03 pmRNSTransaction in Own Shares
4th Mar 20245:48 pmRNSTransaction in Own Shares
1st Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 202410:00 amRNSTotal Voting Rights
1st Mar 20247:46 amRNSDirector Declaration
29th Feb 20246:02 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSFinal Results
28th Feb 20246:05 pmRNSTransaction in Own Shares
27th Feb 20246:04 pmRNSTransaction in Own Shares
26th Feb 20245:59 pmRNSTransaction in Own Shares
23rd Feb 20246:03 pmRNSTransaction in Own Shares
22nd Feb 20245:34 pmRNSTransaction in Own Shares
21st Feb 20245:58 pmRNSTransaction in Own Shares
20th Feb 20245:41 pmRNSTransaction in Own Shares
19th Feb 20245:38 pmRNSTransaction in Own Shares
16th Feb 20245:58 pmRNSTransaction in Own Shares
15th Feb 20246:05 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.